Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue

Journal of Cellular Biochemistry

Volumn 104, Issue 2, 2008, Pages 402-417

  Yang, Xinhai ^a   Solomon, Sandra ^a   Fraser, Lauren R ^b   Trombino, Anthony F ^a   Liu, Donghui ^a   Sonenshein, Gail E ^c   Hestermann, Eli V ^b   Sherr, David H ^a,d  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b FURMAN UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY   (United States)

Author keywords

AhR; CYP1B1; DMBA; Mammary tumors; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST; BREAST TUMOR; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINE; ENVIRONMENTAL FACTOR; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMARY GLAND; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY NEOPLASMS, ANIMAL; PRECANCEROUS CONDITIONS; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER;

RATTUS; RODENTIA;

EID: 43449118697     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21630     Document Type: Article

References (96)

1. Abdelrahim M, Smith R III, Safe S. 2003. Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Mol Pharmacol 63:1373-1381.
2. Beischlag TV, Wang S, Rose DW, Torchia J, Reisz-Porszasz S, Muhammad K, Nelson WE, Probst MR, Rosenfeld MG, Hankinson O. 2002. Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex. Mol Cell Biol 22:4319-4333.
3. Belous AR, Hachey DL, Dawling S, Roodi N, Pari FF. 2007. Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation. Cancer Res 67:812-817.
4. Brody JG, Moysich KB, Humblet O, Attfield KR, Beehler GP, Rudel RA. 2007. Environmental pollutants and breast cancer: Epidemiologic studies. Cancer 109:2667-2711.
5. Burchiel SW, Thompson TA, Lauer FT, Oprea TI. 2007. Activation of dioxin response element (DRE)-associated genes by benzo(a)pyrene 3,6-quinone and benzo(a)pyrene 1,6-quinone in MCF-10A human mammary epithelial cells. Toxicol Appl Pharmacol 221:203-214.
6. Burdick AD, Davis JW II, Liu KJ, Hudson LG, Shi H, Monske ML, Burchiel SW. 2003. Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. Cancer Res 63: 7825-7833.
7. Burdick AD, Ivnitski-Steele ID, Lauer FT, Burchiel SW. 2006. PYK2 mediates anti-apoptotic AKT signaling in response to benzo[a]pyrene diol epoxide in mammary epithelial cells. Carcinogenesis 27:2331-2340.
8. Buters JT, Sakai S, Richter T, Pineau T, Alexander DL, Savas U, Doehmer J, Ward JM, Jefcoate CR, Gonzalez FJ. 1999. Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci USA 96:1977-1982.
9. Cailleau R, Olive M, Cruciger QV. 1978. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro 14:911-915.
10. Calaf G, Russo J. 1993. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14:483-492.
11. Carrier F, Owens R, Nebert D, Puga A. 1992. Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation. Mol Cell Biol 12:1856-1863.
12. Caruso JA, Mathieu PA, Joiakim A, Zhang H, Reiners JJ, Jr. 2006. Aryl hydrocarbon receptor modulation of TNFalpha-induced apoptosis and lysosomal disruption in a hepatoma model that is caspase-8 independent. J Biol Chem 281:10954-10967.
13. Carver LA, LaPres JJ, Jain S, Dunham EE, Bradfield CA. 1998. Characterization of the Ah receptor-associated protein, A RA9. J Biol Chem 273:33580-33587.
14. Chambers D, Wilson L, Maden M, Lumsden A. 2007. RALDH-independent generation of retinoic acid during vertebrate embryogenesis by CYP1 B1. Development 134:1369-1383.
15. Chan MM, Lu X, Merchant FM, Iglehart JD, Miron PL. 2005. Gene expression profiling of NMU-induced rat mammary tumors: Cross species comparison with human breast cancer. Carcinogenesis 26:1343-1353.
16. Chang CY, Puga A. 1998. Constitutive activation of the aromatic hydrocarbon receptor. Mol Cell Biol 18:525-535.
17. Chang JT, Chang H, Chen PH, Lin SL, Lin P. 2007. Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas. Clin Cancer Res 13:38-45.
18. Chen HS, Perdew GH. 1994. Subunit composition of the heteromeric cytosolic aryl hydrocarbon receptor complex. J Biol Chem 269:27554.
19. Chen YH, Beischlag TV, Kim JH, Perdew GH, Stallcup MR. 2006. Role of GAC63 in transcriptional activation mediated by the aryl hydrocarbon receptor. J Biol Chem 281:12242-12247.
20. Christou M, Savas U, Schroeder S, Shen X, Thompson T, Gould MN, Jefcoate CR. 1995. Cytochromes CYP1A1 and CYP1B1 in the rat mammary gland: Cell-specific expression and regulation by polycyclic aromatic hydrocarbons and hormones. Mol Cell Endocrinol 115:41-50.
21. Corton JC. 1996. Overlapping but unique DNA binding specificites of the Ah receptor and constitutive dioxin-responsive element binding proteins from human keratinocytes. Toxicol Lett 85:67-75.
22. Currier N, Solomon S, Demicco E, Chang D, Farago M, Ying H, Dominguez I, Rogers A, Sonenshein G, Cardiff R, Xiao J, Sherr D, Seldin D. 2005. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol Pathol 33:726.
23. Dertinger SD, Nazarenko DA, Silverstone AE, Gasiewicz TA. 2001. Aryl hydrocarbon receptor signaling plays a significant role in mediating benzo[a]pyrene- and cigarette smoke condensate-induced cytogenetic damage in vivo. Carcinogenesis 22:171-177.
24. Dohr O, Vogel C, Abel J. 1995. Different response of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells. Arch Biochem Biophys 321:405-412.
25. Dolwick KM, Swanson HI, Bradfield CA. 1993. In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition. Proc Natl Acad Sci USA 90:8566-8570.
26. Eltom SE, Larsen MC, Jefcoate CR. 1998. Expression of CYP1B1 but not CYP1A1 by primary cultured human mammary stromal fibroblasts constitutively and in response to dioxin exposure: Role of the Ah receptor. Carcinogenesis 19:1437-1444.
27. Ema M, Sogawa K, Watanabe N, Chujoh Y, Matsushita N, Gotoh O, Funae Y, Fujii-Kuriyama Y. 1992. cDNA cloning and structure of mouse putative Ah receptor. Biochem Biophys Res Comm 184:246-253.
28. Hackett AJ, Smith HS, Springer EL, Owens RB, Nelson-Rees WA, Riggs JL, Gardner MB. 1977. Two syngeneic cell lines from human breast tissue: The aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J Natl Cancer Inst 58:1795-1806.
29. Han D, Nagy SR, Denison MS. 2004. Comparison of recombinant cell bioassays for the detection of Ah receptor agonists. Biofactors 20:11-22.
30. Hankinson O. 1995. The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307-340.
31. Hankinson O. 2005. Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Arch Biochem Biophys 433:379-386.
32. Hayashibara T, Yamada Y, Mori N, Harasawa H, Sugahara K, Miyanishi T, Kamihira S, Tomonaga M. 2003. Possible involvement of aryl hydrocarbon receptor (AhR) in adult T-cell leukemia (ATL) leukemogenesis: Constitutive activation of AhR in ATL. Biochem Biophys Res Commun 300:128-134.
33. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. 1996. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1 B1. Proc Natl Acad Sci USA 93:9776-9781.
34. Heath-Pagliuso S, Rogers WJ, Tullis K, Seidel SD, Cenijn PH, Brouwer A, Denison MS. 1998. Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry 37:11508-11515.
35. Henry EC, Bemis JC, Henry O, Kende AS, Gasiewicz TA. 2006. A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo. Arch Biochem Biophys 450:67-77.
36. Hestermann EV, Brown M. 2003. Agonist and chemopreventative ligands induce differential transcriptional cofactor recruitment by aryl hydrocarbon receptor. Mol Cell Biol 23:7920-7925.
37. Ito T, Tsukumo S, Suzuki N, Motohashi H, Yamamoto M, Fujii-Kuriyama Y, Mimura J, Lin TM, Peterson RE, Tohyama C, Nohara K. 2004. A constitutively active arylhydrocarbon receptor induces growth inhibition of jurkat T cells through changes in the expression of genes related to apoptosis and cell cycle arrest. J Biol Chem 279:25204-25210.
38. Karchner SI, Franks DG, Powell WH, Hahn ME. 2002. Regulatory interactions among three members of the vertebrate aryl hydrocarbon receptor family: AHR repressor, AHR1, and A HR2. J Biol Chem 277:6949-6959.
39. Kazlauskas A, Poellinger L, Pongratz I, 1999. Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (aryl hydrocarbon) receptor. J Biol Chem 274:13519-13524.
40. Kazlauskas A, Poellinger L, Pongratz I, 2000. The immunophilin-like protein XAP2 regulates ubiquitination and subcellular localization of the dioxin receptor. J Biol Chem 275:41317-41324.
41. Kumar MB, Perdew GH. 1999. Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential. Gene Expr 8:273-286.
42. Kumar MB, Tarpey RW, Perdew GH. 1999. Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. J Biol Chem 274:22155-22164.
43. Larsen M, Angus WGR, Brake P, Eltom S, Jefcoate CR. 1997. CYP1B1 represents the major PAH-responsive P450 cytochrome constitutively expressed in normal primary HMEC. Fund Appl Tox 36:24.
44. Larsen MC, Brake PB, Pollenz RS, Jefcoate CR. 2004. Linked expression of Ah receptor, ARNT, CYP1A1, and CYP1B1 in rat mammary epithelia, in vitro, is each substantially elevated by specific extracellular matrix interactions that precede branching morphogenesis. Toxicol Sci 82:46-61.
45. Lee SY, Walsh CT, Ng SF, Rogers AE. 1986. Toxicokinetics of 7,12-dimethylbenz[a]anthracene (DMBA) in rats fed high lard or control diets. J Nutr Growth Cancer 3:167-176.
46. Levine-Fridman A, Chen L, Elferink CJ. 2004. Cytochrome P4501A1 Promotes G1 Phase Cell Cycle Progression by Controlling Aryl Hydrocarbon Receptor Activity. Mol Pharmacol 65:461-469.
47. Li D, Wang M, Dhingra K, Hittelman WN. 1996. Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology. Cancer Res 56:287-293.
48. Li D, Zhang W, Sahin AA, Hittelman WN. 1999. DNA adducts in normal tissue adjacent to breast cancer: A review. Cancer Detect Prev 23:454-462.
49. Liehr JG, Ricci MJ. 1996. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 93:3294-3296.
50. Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA, Zhu BT. 1995. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: Implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci USA 92:9220-9224.
51. Ma Q, Whitlock J. 1996. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol Cell Biol 16:2144-2150.
52. Maecker B, Sherr DH, Vonderheide RH, von Bergwelt-Baildon MS, Hirano N, Anderson KS, Xia Z, Butler MO, Wucherpfennig KW, O'Hara C, Cole G, Kwak SS, Ramstedt U, Tomlinson AJ, Chicz RM, Nadler LM, Schultze JL. 2003. The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells. Blood 102:3287-3294.
53. Mahon M, Gasiewicz T. 1995. Ah Receptor phosphorylation: Localization of phosphorylation sites to the C-terminal half of the protein. Arch Biochem Biophys 318:166-174.
54. Medina D. 1974. Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in Balb-c and C57BL/6 mice. J Natl Cancer Inst 53:213-221.
55. Meyer BK, Pray-Grant MG, Vanden Heuvel JP, Perdew GH. 1998. Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Mol Cell Biol 18:978-988.
56. Murray GI, Taylor MC, McFadyen MC, McKay JA, Greenlee WF, Burke MD, Melvin WT. 1997. Tumor-specific expression of cytochrome P450 CYP1 B1. Cancer Res 57:3026-3031.
57. Murray IA, Reen RK, Leathery N, Ramadoss P, Bonati L, Gonzalez FJ, Peters JM, Perdew GH. 2005. Evidence that ligand binding is a key determinant of Ah receptor-mediated transcriptional activity. Arch Biochem Biophys 442:59-71.
58. Murray TJ, Yang X, Sherr DH. 2006. Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A. Breast Cancer Res 8:R17.
59. N'Diaye M, Le Ferrec E, Lagadic-Gossmann D, Corre S, Gilot D, Lecureur V, Monteiro P, Rauch C, Galibert MD, Fardel O. 2006. Aryl hydrocarbon receptor- and calcium-dependent induction of the chemokine CCL1 by the environmental contaminant benzo[a]pyrene. J Biol Chem 281:19906-19915.
60. Nguyen TA, Hoivik D, Lee JE, Safe S. 1999. Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Arch Biochem Biophys 367:250-257.
61. Perdew G, Bradfield C. 1996. Mapping the 90 kDa heat shock protein binding region of the Ah receptor. Biochem Mol Biol Int 39:589-593.
62. Petersen OW, Nielsen HL, Gudjonsson T, Villadsen R, Rank F, Niebuhr E, Bissell MJ, Ronnov-Jessen L. 2003. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am J Pathol 162:391-402.
63. Phelan D, Winter GM, Rogers WJ, Lam JC, Denison MS. 1998. Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch Biochem Biophys 357:155-163.
64. Poland A, Glover E, Bradfield CA. 1990. Characterization of polyclonal antibodies to the Ah receptor prepared by immunization with a synthetic peptide hapten. Mol Pharmacol 39:20-26.
65. Robles R, Morita Y, Mann KK, Perez GI, Yang S, Matikainen T, Sherr DH, Tilly JL. 2000. The aryl hydrocarbon receptor, a basic helix-loop-helix transcription factor of the PAS gene family, is required for normal ovarian germ cell dynamics in the mouse. Endocrinology 141:450-453.
66. Rogers A, Conner B. 1990. Dimethylbenzanthracene-induced mammary tumorigenesis in ethanol-fed rats. Nutr Res 10:915-928.
67. Russo J, Russo I, Zwieten MV, Rogers A, Gusterson B. 1989. Classification of neoplastic and non neoplastic lesions of the rat mammary gland. Berlin: Springer-Verlang.
68. Santella RM, Gammon M, Terry M, Senie R, Shen J, Kennedy D, Agrawal M, Faraglia B, Zhang F. 2005. DNA adducts, DNA repair genotype/phenotype and cancer risk. Mutat Res 592:29-35.
69. Schlezinger J, Liu D, Farago M, Seldin D, Belguise K, Sonenshein G, Sherr D. 2006. A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biol Chem 387:1175-1187.
70. Sellers TA, Schildkraut JM, Pankratz VS, Vierkant RA, Fredericksen ZS, Olson JE, Cunningham J, Taylor W, Liebow M, McPherson C, Hartmann LC, Pal T, Adjei AA. 2005. Estrogen bioactivation, genetic polymorphisms, and ovarian cancer. Cancer Epidemiol Biomarkers Prev 14:2536-2543.
71. Shehin SE, Stephenson RO, Greenlee WF. 2000. Transcriptional regulation of the human CYP1B1 gene. Evidence for involvement of an aryl hydrocarbon receptor response element in constitutive expression. J Biol Chem 275:6770-6776.
72. Shen J, Gammon MD, Terry MB, Wang L, Wang Q, Zhang F, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI, Santella RM. 2005. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:336-342.
73. Shen J, Beth Terry M, Gammon MD, Gaudet MM, Teitelbaum SL, Eng SM, Sagiv SK, Neugut AI, Santella RM. 2006. IGHMBP2 Thr671A1a polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk. Breast Cancer Res Treat 99:1-7.
74. Singh SS, Hord NG, Perdew GH. 1996. Characterization of the activated form of the aryl hydrocarbon receptor in the nucleus of HeLa cells in the absence of exogenous ligand. Arch Biochem Biophys 329:47-55.
75. Soule H, Maloney T, Wolman S, Peterson W, Brenz R, McGrath C, Russo J, Pauley R, Jones R, Brooks S. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075-6086.
76. Spink DC, Hayes CL, Young NR, Christou M, Sutter TR, Jefcoate CR, Gierthy JF. 1994. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: Evidence for induction of a novel 17 beta-estradiol 4-hydroxylase. J Steroid Biochem Mol Biol 51:251-258.
77. Spink DC, Spink BC, Cao JQ, DePasquale JA, Pentecost BT, Fasco MJ, Li Y, Sutter TR. 1998. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19: 291-298.
78. Spink BC, Pang S, Pentecost BT, Spink DC. 2002. Induction of cytochrome P450 1B1 in MDA-MB-231 human breast cancer cells by non-ortho-substituted polychlorinated biphenyls. Toxicol In Vitro 16:695-704.
79. Spink BC, Hussain MM, Katz BH, Eisele L, Spink DC. 2003a. Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin. Biochem Pharmacol 66:2313-2321.
80. Spink DC, Katz BH, Hussain MM, Pentecost BT, Cao Z, Spink BC. 2003b. Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis 24:1941-1950.
81. Stampfer M. 1985. Isolation and growth of human mammary epithelial cells. J Tissue Cult Methods 9:107-116.
82. Stampfer M, Bartley J. 1985. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a) pyrene. Proc Natl Acad Sci USA 82:2394-2398.
83. Swanson HI. 2002. DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation. Chem Biol Interact 141:63-76.
84. Swanson HI, Yang JH. 1998. The aryl hydrocarbon receptor interacts with transcription factor IIB. Mol Pharmacol 54:671-677.
85. Swanson HI, Chan WK, Bradfield CA. 1995. DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins. J Biol Chem 270:26292-26302.
86. Terry MB, Gammon MD, Zhang FF, Eng SM, Sagiv SK, Paykin AB, Wang Q, Hayes S, Teitelbaum SL, Neugut AI, Santella RM. 2004. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 13:2053-2058.
87. Tokizane T, Shiina H, Igawa M, Enokida H, Urakami S, Kawakami T, Ogishima T, Okino ST, Li LC, Tanaka Y, Nonomura N, Okuyama A, Dahiya R. 2005. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res 11:5793-5801.
88. Trombino AF, Matulka RA, Yang S, Hafer LJ, Rogers AE, Tosselli P, Kim D, Sonenshein GE, Near RI, Sherr DH. 2000. Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcription in a rat model of mammary tumorigenesis. Breast Cancer Res Treat 62:117-131.
89. Walen KH, Stampfer MR. 1989. Chromosome analyses of human mammary epithelial cells at stages of chemical-induced transformation progression to immortality. Cancer Genet Cytogenet 37:249-261.
90. Wang S, Hankinson O. 2002. Functional involvement of the Brahma/SWI2-related gene 1 protein in cytochrome P4501A1 transcription mediated by the aryl hydrocarbon receptor complex. J Biol Chem 277:11821-11827.
91. Wang F, Wang W, Safe S. 1999. Regulation of constitutive gene expression through interactions of Sp1 protein with the nuclear aryl hydrocarbon receptor complex. Biochemistry 38:11490-11500.
92. Wang S, Ge K, Roeder RG, Hankinson O. 2004. Role of mediator in transcriptional activation by the aryl hydrocarbon receptor. J Biol Chem 279:13593-13600.
93. Watanabe J, Shimad T, Gillam E, Ikuta T, Suemasu K, Higashi Y, Gotoh O, Kawajiri K. 2000. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogen 10:25-33.
94. Wei YD, Tepperman K, Huang MY, Sartor MA, Puga A. 2004. Chromium inhibits transcription from polycyclic aromatic hydrocarbon-inducible promoters by blocking the release of histone deacetylase and preventing the binding of p300 to chromatin. J Biol Chem 279:4110-4119.
95. Yang X, Liu D, Murray T, Mitchell G, Hestermann D, Karchner S, Merson R, Hahn M, Sherr D. 2005. The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cells. Oncogene 24:7869.
96. Yu WC, Leung BS, Gao YL. 1981. Effects of 17 b-estradiol on progesterone receptors and the uptake of thymidine in human breast cancer cell line CAMA-1. Cancer Res 41: 5004-5009.